Neutrophil elastase and acute lung injury: Prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics

Bernhardt Zeiher, Shozo Matsuoka, Kazuhito Kawabata, John E. Repine

Critical Care Medicine · 2002 · 130 citations · 33 references

Abstract

Further study of the role of NE inhibition as a treatment for ALI is warranted. Additional clinical and preclinical studies with sivelestat and various other NE inhibitors should not only clarify the clinical potential of this intervention strategy, but also better define the activities of NE in inflammatory disorders such as ALI and multiple organ failure.

References

33